Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-155693
Filing Date
2004-09-13
Accepted
2004-09-13 16:40:24
Documents
7
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR ENDED JUNE 30, 2004 d10k.htm 10-K 615334
2 FORM OF CHANGE IN CONTROL AGREEMENT BETWEEN THE COMPANY AND EXECUTIVE OFFICERS dex103.htm EX-10.3 21121
3 LETTER BETWEEN UROLOGIX, INC. AND FRED B. PARKS DATED AS OF JULY 19, 2004 dex105.htm EX-10.5 6172
4 CONSENT OF KPMG LLP dex231.htm EX-23.1 1971
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 7305
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 8463
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 3325
  Complete submission text file 0001193125-04-155693.txt   666116
Mailing Address 14405 21ST AVENUE NORTH MINNEAPOLIS MN 55447
Business Address 14405 21ST AVE N MINNEAPOLIS MN 55447 6124751400
UROLOGIX INC (Filer) CIK: 0000882873 (see all company filings)

EIN.: 411697237 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-28414 | Film No.: 041027854
SIC: 3845 Electromedical & Electrotherapeutic Apparatus